Skip to content
10-Q

Quarterly Report

AVAI BIO, INC. AVAI

0001740797-25-000054

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2026 · Nov 14, 2025 138.03M sh
Operating Cash Flow Q2 2026 · Sep 30, 2025 −$611.89K
Cash And Equivalents Q2 2026 · Sep 30, 2025 $92K
Cash And Equivalents Q2 2026 · Mar 31, 2025 $81.05K
Stockholders Equity Q2 2026 · Sep 30, 2025 −$2.3M
Stockholders Equity Q2 2026 · Jun 30, 2025 −$1.99M
Stockholders Equity Q2 2026 · Mar 31, 2025 −$1.56M
Current Liabilities Q2 2026 · Sep 30, 2025 $2.53M
Current Liabilities Q2 2026 · Mar 31, 2025 $1.79M
Total Liabilities Q2 2026 · Sep 30, 2025 $2.53M
Total Liabilities Q2 2026 · Mar 31, 2025 $1.79M
Current Assets Q2 2026 · Sep 30, 2025 $112.8K
Current Assets Q2 2026 · Mar 31, 2025 $93.13K
Total Assets Q2 2026 · Sep 30, 2025 $231.37K
Total Assets Q2 2026 · Mar 31, 2025 $224.75K
Eps Basic Q2 2026 · Sep 30, 2025 $0.00
Eps Basic Q2 2026 · Sep 30, 2025 −$0.01
Sga Expense Q2 2026 · Sep 30, 2025 $265.02K
Sga Expense Q2 2026 · Sep 30, 2025 $478.91K
Rd Expense Q2 2026 · Sep 30, 2025 $23.8K
Rd Expense Q2 2026 · Sep 30, 2025 $23.8K
Net Income Q2 2026 · Sep 30, 2025 −$453.02K
Net Income Q2 2026 · Jun 30, 2025 −$487.59K
Operating Income Q2 2026 · Sep 30, 2025 −$453.02K
Operating Income Q2 2026 · Sep 30, 2025 −$940.61K
Operating Income Q2 2026 · Sep 30, 2024 $623.05K
Operating Income Q2 2026 · Sep 30, 2024 $1.15M